Institutional shares held 197,682
0 calls
0 puts
Total value of holdings $3K
$0 calls
$0 puts
Market Cap $2.24M
112,150,000 Shares Out.
Institutional ownership 0.18%
# of Institutions 2


Latest Institutional Activity in VAXX

Top Purchases

Q2 2024
Spire Wealth Management Shares Held: 162K ($3.24K)
Q2 2024
Xtx Topco LTD Shares Held: 67.1K ($1.34K)
Q1 2024
Stelac Advisory Services LLC Shares Held: 140K ($2.81K)
Q1 2024
Morgan Stanley Shares Held: 62.2K ($1.24K)
Q1 2024
Jpmorgan Chase & CO Shares Held: 44.9K ($898)

Top Sells

Q2 2024
Barclays PLC Shares Held: 2 ($0.04)
Q2 2024
Advisor Group Holdings, Inc. Shares Held: 2.39K ($47.7)
Q1 2024
Bank Of America Corp Shares Held: 92K ($1.84K)
Q1 2024
Black Rock Inc. Shares Held: 2.62M ($52.5K)
Q1 2024
Raymond James Financial Services Advisors, Inc. Shares Held: 11.2K ($223)

About VAXX

Vaxxinity, Inc., a biotechnology company, focuses on developing product candidates for human use in the fields of neurology and coronaviruses in the United States. The company engages in developing UB-311 that targets toxic forms of aggregated amyloid-b in the brain to fight Alzheimer's disease (AD) that is in phase 2 clinical trial; UB-312 that targets toxic forms of aggregated a-synuclein in the brain to fight Parkinson's disease and other synucleinopathies, such as Lewy body dementia and multiple system atrophy that is in phase 1 clinical trial; and an anti-tau product candidate for various neurodegenerative conditions, including AD. It is also developing UB-313 that targets calcitonin gene-related peptide to fight migraines; anti-PCSK9 that targets proprotein convertase subtilisin/kexin type 9 serine protease to lower low-density lipoprotein cholesterol and reduce the risk of cardiac events; and UB-612 for neutralizing the SARS-CoV-2 virus, which is in phase 3 clinical trial. Vaxxinity, Inc. was founded in 2014 and is headquartered in Dallas, Texas.


Insider Transactions at VAXX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on VAXX

Follow Vaxxinity, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells VAXX shares.

Notify only if
Any

Insider Trading

Get notified when an Vaxxinity, Inc. insider buys or sells VAXX shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Vaxxinity, Inc.

Track Activities on VAXX